Mark Sharrard

853 total citations
21 papers, 439 citations indexed

About

Mark Sharrard is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Sharrard has authored 21 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 11 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Sharrard's work include Metabolism and Genetic Disorders (12 papers), Biochemical and Molecular Research (7 papers) and Mitochondrial Function and Pathology (4 papers). Mark Sharrard is often cited by papers focused on Metabolism and Genetic Disorders (12 papers), Biochemical and Molecular Research (7 papers) and Mitochondrial Function and Pathology (4 papers). Mark Sharrard collaborates with scholars based in United Kingdom, United States and France. Mark Sharrard's co-authors include James R. Bonham, S. E. Olpin, N. J. Manning, M. Downing, M S Tanner, Nicholas Beauchamp, Ann Dalton, Stuart Tanner, Younès Achouri and Valérie Race and has published in prestigious journals such as Neuroscience, The American Journal of Human Genetics and Archives of Disease in Childhood.

In The Last Decade

Mark Sharrard

20 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sharrard United Kingdom 10 212 178 116 105 75 21 439
Sema Kalkan Uçar Türkiye 14 205 1.0× 113 0.6× 99 0.9× 88 0.8× 29 0.4× 86 632
Merçè Pineda Spain 13 302 1.4× 300 1.7× 179 1.5× 78 0.7× 80 1.1× 19 562
Roberto Della Casa Italy 16 138 0.7× 103 0.6× 311 2.7× 166 1.6× 42 0.6× 34 536
Dorothea Möslinger Austria 14 274 1.3× 358 2.0× 133 1.1× 76 0.7× 52 0.7× 31 572
Matthias Zielonka Germany 15 195 0.9× 127 0.7× 33 0.3× 74 0.7× 28 0.4× 29 451
S. B. van der Meer Netherlands 14 207 1.0× 202 1.1× 76 0.7× 91 0.9× 26 0.3× 19 564
Mike Champion United Kingdom 6 191 0.9× 198 1.1× 80 0.7× 55 0.5× 24 0.3× 6 357
Toju Tanaka Japan 10 101 0.5× 135 0.8× 106 0.9× 27 0.3× 30 0.4× 16 417
Komudi Siriwardena Canada 13 279 1.3× 255 1.4× 128 1.1× 278 2.6× 49 0.7× 25 671
Helen Prunty United Kingdom 8 162 0.8× 160 0.9× 121 1.0× 46 0.4× 61 0.8× 19 356

Countries citing papers authored by Mark Sharrard

Since Specialization
Citations

This map shows the geographic impact of Mark Sharrard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sharrard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sharrard more than expected).

Fields of papers citing papers by Mark Sharrard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sharrard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sharrard. The network helps show where Mark Sharrard may publish in the future.

Co-authorship network of co-authors of Mark Sharrard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sharrard. A scholar is included among the top collaborators of Mark Sharrard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sharrard. Mark Sharrard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwahn, Bernd, Anthony R Hart, Lynette D. Fairbanks, et al.. (2024). cPMP rescue of a neonate with severe molybdenum cofactor deficiency after serendipitous early diagnosis, and characterisation of a novel MOCS1 variant. Molecular Genetics and Metabolism. 143(4). 108598–108598. 3 indexed citations
2.
Carling, Rachel S., Anupam Chakrapani, Patricia Hall, et al.. (2024). Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK. International Journal of Neonatal Screening. 10(1). 24–24.
3.
Baxter, Peter, et al.. (2021). Post‐Treatment Movement Disorder in a Child with Late‐onset Cobalamin Deficiency. Movement Disorders Clinical Practice. 9(2). 245–248. 1 indexed citations
4.
Sharma, Ruchi, Mark Sharrard, Daniel Connolly, & Santosh Mordekar. (2011). Unilateral periventricular leukomalacia in association with pyruvate dehydrogenase deficiency. Developmental Medicine & Child Neurology. 54(5). 469–471. 6 indexed citations
5.
Manning, N. J., et al.. (2011). Riboflavin-Responsive Trimethylaminuria in a Patient with Homocystinuria on Betaine Therapy. JIMD Reports. 5. 71–75. 9 indexed citations
6.
Griffiths, Paul D., Ruth Batty, Daniel Warren, et al.. (2011). The use of MR imaging and spectroscopy of the brain in children investigated for developmental delay: What is the most appropriate imaging strategy?. European Radiology. 21(9). 1820–1830. 18 indexed citations
7.
Sharrard, Mark, et al.. (2010). Recurrent vomiting and lethargy in an infant--just another viral illness?. BMJ. 341(aug04 1). c1037–c1037. 1 indexed citations
8.
9.
Race, Valérie, Younès Achouri, Elsa Wiame, et al.. (2007). Phosphoserine Aminotransferase Deficiency: A Novel Disorder of the Serine Biosynthesis Pathway. The American Journal of Human Genetics. 80(5). 931–937. 89 indexed citations
10.
Warren, Daniel, Daniel Connolly, Iain D. Wilkinson, Mark Sharrard, & Paul D. Griffiths. (2007). Magnetic resonance spectroscopy changes following haemopoietic stem cell transplantation in children with cerebral adrenoleukodystrophy. Developmental Medicine & Child Neurology. 49(2). 135–139. 8 indexed citations
11.
Beauchamp, Nicholas, Ann Dalton, Uma Ramaswami, et al.. (2007). Glycogen storage disease type IX: High variability in clinical phenotype. Molecular Genetics and Metabolism. 92(1-2). 88–99. 90 indexed citations
12.
Beauchamp, Nicholas, Joanna Taybert, M. P. Champion, et al.. (2007). High frequency of missense mutations in glycogen storage disease type VI. Journal of Inherited Metabolic Disease. 30(5). 722–734. 31 indexed citations
13.
Sharrard, Mark & R. J. Pollitt. (2007). Metabolic screening in children: newborn screening for metabolic diseases past, present and future. Paediatrics and Child Health. 17(7). 273–278. 5 indexed citations
14.
Mordekar, Santosh, Tim Jaspan, Mark Sharrard, Richard E. Morton, & William Whitehouse. (2005). Acute bilateral striatal necrosis with rotavirus gastroenteritis and inborn metabolic predisposition. Developmental Medicine & Child Neurology. 47(6). 415–418. 8 indexed citations
15.
Olpin, S. E., Brage Storstein Andresen, Claus Bischoff, et al.. (2004). Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. Journal of Inherited Metabolic Disease. 28(4). 533–544. 54 indexed citations
16.
Nassogne, Marie‐Cécile, Mark Sharrard, Lucie Hertz‐Pannier, et al.. (2002). Massive subdural haematomas in Menkes disease mimicking shaken baby syndrome. Child s Nervous System. 18(12). 729–731. 40 indexed citations
17.
Bonham, James R., Philip A. I. Guthrie, M. Downing, et al.. (1999). The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. Journal of Inherited Metabolic Disease. 22(2). 174–184. 26 indexed citations
18.
Olpin, S. E., James R. Bonham, M. Downing, et al.. (1997). Carnitine‐acylcarnitine translocase deficiency ‐ a mild phenotype. Journal of Inherited Metabolic Disease. 20(5). 714–715. 29 indexed citations
19.
Gallagher, J.A., J.N. Beresford, Mark Sharrard, James W. Poser, & R.G.G. Russell. (1983). Hormonal regulation of osteocalcin production by human bone cells in vitro. Metabolic Bone Disease and Related Research. 5(1). 49–49. 2 indexed citations
20.
Banks, Peter A., et al.. (1978). The formation of actin-containing gels by extracts of bovine splenic nerve. Neuroscience. 3(11). 1109–1116. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sema Kalkan Uçar Breakdown of academic impact, for papers by Merçè Pineda Breakdown of academic impact, for papers by Roberto Della Casa Breakdown of academic impact, for papers by Dorothea Möslinger Breakdown of academic impact, for papers by Matthias Zielonka Breakdown of academic impact, for papers by S. B. van der Meer Breakdown of academic impact, for papers by Mike Champion Breakdown of academic impact, for papers by Toju Tanaka Breakdown of academic impact, for papers by Komudi Siriwardena Breakdown of academic impact, for papers by Helen Prunty
Rankless by CCL
2026